Ally Bridge Group is a global healthcare-focused investment group committed to venture and growth capital, buyout, and hedge fund investing.
Ally Bridge Group is a global healthcare-focused investment group committed to venture and growth capital, buyout, and hedge fund investing.Ally Bridge Group was founded by Frank Yu in July 2013 and is based in New York and Hong Kong.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 11, 2022
Transcarent
|
Series C | $200M | Health Care | — |
Jan 7, 2021
IsoPlexis
|
Series D | $85M | Biotechnology | — |
Jan 7, 2021
IsoPlexis
|
Debt Financing | $50M | Biotechnology | — |
Dec 4, 2019
Venclose
|
Series C | $27M | Biotechnology | Yes |
May 16, 2017
Synlogic
|
Series C | $42M | Biotechnology | — |